Article Information
History
- November 1, 2023.
Article Versions
- Version 1 (July 5, 2022 - 15:48).
- Version 2 (January 5, 2023 - 14:18).
- You are viewing Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Albert Ziye Ma1,#,
- Brian D. Kirk2,#,
- Deyu Yan3,
- Mingchao Zhang5,
- Jing Yao2,
- Xiaomin Dai3,
- Lingdan Lu6,
- Qinghua Wang4,
- Weihai Ying5,+,* and
- Yan Han6,*
- 1Shanghai American School, 1600 Lingbai Road, Shanghai, China 201201
- 2Multiscale Research Institute for Complex Systems, Fudan University, 653 Huatuo Road, Shanghai, China 201203
- 3Shanghai AI Laboratory, Shanghai, China
- 4Center for Biomolecular Innovation, Harcam Biomedicines, Shanghai, China
- 5School of Biomedical Engineering and Med-X Institute, Shanghai Jiao Tong University, Shanghai, China
- 6Department of Neurology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China 200437
- ↵+Correspondence to: Dr. Weihai Ying, School of Biomedical Engineering and Med-X Institute, Shanghai Jiao Tong University, Shanghai, China. Email: weihaiy{at}sjtu.edu.cn, Phone: (86)130- 5221-8008.
Posted November 01, 2023.
Single-cell transcriptional landscape of peripheral immunity and biomarkers for human sporadic amyotrophic lateral sclerosis patients
